Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biohaven Ltd
(NY:
BHVN
)
40.83
-0.17 (-0.43%)
Streaming Delayed Price
Updated: 1:36 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biohaven Ltd
< Previous
1
2
3
4
5
6
7
8
9
Next >
BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024
August 09, 2024
BHVN stock results show that Biohaven missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
July 22, 2024
Via
Benzinga
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
June 28, 2024
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector.
Via
InvestorPlace
HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday
May 30, 2024
Via
Benzinga
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
May 30, 2024
Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday.
Via
Investor's Business Daily
BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024
May 09, 2024
BHVN stock results show that Biohaven missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
May 29, 2024
Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 29, 2024
Via
Benzinga
What's Going On With Biohaven Stock Wednesday?
May 29, 2024
The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates.
Via
Benzinga
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
May 29, 2024
The company says it's still running additional testing of the drug, calling the results "positive."
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.
Via
Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
Via
Benzinga
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
May 13, 2024
Via
Benzinga
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
May 01, 2024
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.
Via
InvestorPlace
Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
April 26, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip.
Via
InvestorPlace
Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
March 27, 2024
Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipose tissue, and results in obesity and Metabolic dysfunction-associated...
Via
Benzinga
Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
March 26, 2024
Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its...
Via
Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...
Via
Benzinga
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/8
March 08, 2024
Via
Investor Brand Network
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/4
March 04, 2024
Via
Investor Brand Network
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset...
Via
Benzinga
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
January 25, 2024
The best weight-loss drug stocks firms improving the drugs or developing new, potentially superior weight-loss treatments.
Via
InvestorPlace
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 1/5
January 05, 2024
Via
Investor Brand Network
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Based on good technical signals, BIOHAVEN LTD is potentially setting up for a breakout.
November 24, 2023
BIOHAVEN LTD (NYSE:BHVN) showing some interesting technicals. Here's why.
Via
Chartmill
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Sets New 52-Week High in Monday Session
November 20, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.